Virios Therapeutics Inc
Research Virios Therapeutics Inc (DWTX) on Bullrun: market cap USD 90.13M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDWTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 90.13M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 4.99M
- Free cash flow-USD 15.52M
Valuation Snapshot
latest market cap is USD 90.13M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 34.26M | -USD 15.62M | n/a | -7.13 | USD 6.52M | USD 162.60K | USD 74.90M |
| FY2024 | USD 0 | -USD 12.35M | -USD 8.79M | n/a | -12.52 | USD 14.85M | USD 15.59M | -USD 10.12M |
| FY2023 | n/a | -USD 5.30M | n/a | n/a | -7.05 | USD 3.32M | USD 0 | USD 3.81M |
| FY2022 | n/a | -USD 12.25M | n/a | n/a | -1.11 | USD 7.03M | n/a | USD 7.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 90.13M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 123.73M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.32M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 11.08M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 4.33M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 42.61M | n/a | n/a | n/a |
About Virios Therapeutics Inc
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Virios Therapeutics Inc's market cap?
Virios Therapeutics Inc's market capitalization is USD 90.13M.
What does Virios Therapeutics Inc do?
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.